ArticleOncogene2018

PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.

X Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.